NWM
BIO icon

Navigoe Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Navigoe Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+2
New +$567 ﹤0.01% 508
2026
Q1 		– Sell
-46
Closed -$13K – 224
2025
Q4 		$13K Hold
46
– – 0.01% 135
2025
Q3 		$12K Buy
+46
New +$12.5K 0.01% 141

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Navigoe Wealth Management's BIO Position: Q2 2026 in Review

Navigoe Wealth Management opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #508 among its holdings. This is a return to the name: Navigoe Wealth Management previously reported a position in BIO as recently as Q4 2025.

Navigoe Wealth Management first reported a position in BIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $13K in Q4 2025. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Navigoe Wealth Management held 2 shares of Bio-Rad Laboratories Class A worth $0 as of Q2 2026.
  • Bio-Rad Laboratories Class A was a new Navigoe Wealth Management position in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Navigoe Wealth Management's portfolio in Q2 2026, its #508 holding.
  • Navigoe Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 3 quarters since.
  • Navigoe Wealth Management's Bio-Rad Laboratories Class A position peaked at $13K in Q4 2025.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Navigoe Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.